|
CA2413702A1
(en)
|
2000-06-28 |
2002-01-03 |
Teva Pharmaceuticals Industries Ltd. |
Carvedilol
|
|
ATE364382T1
(de)
*
|
2001-08-13 |
2007-07-15 |
Max Planck Gesellschaft |
Hemmer der aggregation von polyq
|
|
GB0119865D0
(en)
*
|
2001-08-14 |
2001-10-10 |
Cancer Res Campaign Tech |
DNA-PK inhibitors
|
|
PL370412A1
(en)
*
|
2001-09-28 |
2005-05-30 |
F.Hoffmann-La Roche Ag |
Pseudopolymorphic forms of carvedilol
|
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
DE10156894A1
(de)
*
|
2001-11-20 |
2003-05-28 |
Bayer Ag |
Harnstoffe
|
|
KR101018318B1
(ko)
*
|
2001-12-21 |
2011-03-04 |
노보 노르디스크 에이/에스 |
Ｇｋ 활성제로서의 아미드 유도체
|
|
US6710184B2
(en)
*
|
2002-01-15 |
2004-03-23 |
Teva Pharmaceutical Industries Ltd. |
Crystalline solids of carvedilol and processes for their preparation
|
|
JP2006500320A
(ja)
*
|
2002-04-30 |
2006-01-05 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール一クエン酸塩一水和物
|
|
AU2003231307A1
(en)
*
|
2002-05-03 |
2003-11-17 |
Smithkline Beecham Pharmco Puerto Rico, Inc. |
Carvedilol pharmasolve solvate
|
|
TW200307542A
(en)
*
|
2002-05-30 |
2003-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
CA2492084A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol hydobromide
|
|
CA2744893A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as glucokinase activators
|
|
BR0312102A
(pt)
*
|
2002-06-27 |
2007-05-29 |
Sb Pharmco Inc |
sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento
|
|
US7915301B2
(en)
*
|
2002-07-08 |
2011-03-29 |
Piramal Life Science Limited |
Inhibitors of cyclin dependent kinases and their use
|
|
US20040152756A1
(en)
*
|
2002-07-15 |
2004-08-05 |
Wei Chen |
Carvedilol polymorph
|
|
DK1521752T3
(da)
*
|
2002-07-15 |
2009-06-22 |
Helmholtz Infektionsforschung |
Makrocykliske forbindelser til behandling af cancer
|
|
SE0202241D0
(sv)
*
|
2002-07-17 |
2002-07-17 |
Astrazeneca Ab |
Novel Compounds
|
|
TW200407127A
(en)
*
|
2002-08-21 |
2004-05-16 |
Astrazeneca Ab |
Chemical compounds
|
|
SK285547B6
(sk)
*
|
2002-11-08 |
2007-03-01 |
Zentiva, A. S. |
Spôsob prípravy Carvedilolu
|
|
US7645782B2
(en)
*
|
2002-11-28 |
2010-01-12 |
Wolfgang Richter |
Thia-epothilone derivatives for the treatment of cancer
|
|
EP1571146A4
(en)
*
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
|
US20060166983A1
(en)
*
|
2003-01-06 |
2006-07-27 |
Eli Lilly And Company |
Indole derivatives as ppar modulators
|
|
RS20050532A
(sr)
*
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
|
|
SE0301010D0
(sv)
*
|
2003-04-07 |
2003-04-07 |
Astrazeneca Ab |
Novel compounds
|
|
SE0301009D0
(sv)
*
|
2003-04-07 |
2003-04-07 |
Astrazeneca Ab |
Novel compounds
|
|
GB0308186D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2004094378A1
(en)
|
2003-04-21 |
2004-11-04 |
Matrix Laboratories Ltd |
Process for the preparation of carvedilol form-ii
|
|
RU2396250C2
(ru)
*
|
2003-07-24 |
2010-08-10 |
Лео Фарма А/С |
Новые производные аминобензофенона
|
|
KR20060066722A
(ko)
*
|
2003-08-13 |
2006-06-16 |
쿠도스 파마슈티칼스 리미티드 |
아미노피론 및 ａｔｍ억제제로서의 이의 용도
|
|
SA04250253B1
(ar)
|
2003-08-21 |
2009-11-10 |
استرازينيكا ايه بي |
احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
|
|
SI21616A
(sl)
*
|
2003-09-02 |
2005-04-30 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nove kristalne oblike karvedilola
|
|
EP1677783A2
(en)
*
|
2003-10-08 |
2006-07-12 |
Nicholas Piramal India Limited |
Fibrinogen receptor antagonists and their use
|
|
TWI258478B
(en)
|
2003-10-31 |
2006-07-21 |
Arena Pharm Inc |
Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
|
|
JP5072364B2
(ja)
*
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム （コーク） リミテッド |
カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
|
|
JP2007512372A
(ja)
*
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール塩、対応する組成物、送達および／または治療方法
|
|
EP1686967A4
(en)
*
|
2003-11-25 |
2012-08-08 |
Smithkline Beecham Cork Ltd |
CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
|
|
BRPI0506662B8
(pt)
*
|
2004-01-06 |
2021-05-25 |
Novo Nordisk As |
compostos ativadores de glucoquinase
|
|
US20070105770A1
(en)
*
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
|
EP1723107A2
(en)
|
2004-02-23 |
2006-11-22 |
Cadila Healthcare Ltd. |
Process for manufacture of racemic carvedilol
|
|
MXPA06011410A
(es)
*
|
2004-03-31 |
2007-04-20 |
Johnson & Johnson |
Compuestos heterociclicos sin imidazol como moduladores de receptor de histamina h3.
|
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
|
NZ550114A
(en)
*
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
EP3581564A1
(en)
|
2004-05-05 |
2019-12-18 |
Pfizer Products Inc. |
Diethylamine salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
|
|
GB0411273D0
(en)
*
|
2004-05-20 |
2004-06-23 |
Cipla Ltd |
Process and product
|
|
US7638513B2
(en)
*
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
PE20060426A1
(es)
*
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
|
US20070167426A1
(en)
*
|
2004-06-02 |
2007-07-19 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders and microbial diseases
|
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
GB0418613D0
(en)
*
|
2004-08-20 |
2004-09-22 |
Pugh Rhoderick |
Internet security system
|
|
GB0418830D0
(en)
|
2004-08-24 |
2004-09-22 |
Astrazeneca Ab |
Novel compounds
|
|
RU2408596C2
(ru)
*
|
2004-09-20 |
2011-01-10 |
Кудос Фармасьютикалс Лимитед |
Ингибиторы днк-пк
|
|
ATE489961T1
(de)
*
|
2004-09-30 |
2010-12-15 |
Kowa Co |
Par-2-antagonisten
|
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
|
GB0422057D0
(en)
*
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
GB0422263D0
(en)
*
|
2004-10-07 |
2004-11-10 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2007004403A
(es)
*
|
2004-10-12 |
2007-04-27 |
Astrazeneca Ab |
Derivados de quinazolina.
|
|
TW200630337A
(en)
*
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
|
DE102004051024A1
(de)
*
|
2004-10-20 |
2006-04-27 |
Bayer Healthcare Ag |
Heterocyclyl-substituierte Nonadepsipeptide
|
|
DE102004051025A1
(de)
*
|
2004-10-20 |
2006-04-27 |
Bayer Healthcare Ag |
Substituierte Nonadepsipeptide
|
|
DE102004051023A1
(de)
*
|
2004-10-20 |
2006-05-04 |
Bayer Healthcare Ag |
Desoxo-Nonadepsipeptide
|
|
DE102004053410A1
(de)
*
|
2004-11-05 |
2006-05-11 |
Bayer Healthcare Ag |
Cyclische Nonadepsipeptidamide
|
|
US8692002B2
(en)
*
|
2004-11-18 |
2014-04-08 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
|
EP1817282B1
(en)
*
|
2004-11-23 |
2011-07-20 |
AstraZeneca AB |
Phenoxyacetic acid derivatives useful for treating respiratory diseases
|
|
US7700597B2
(en)
*
|
2004-12-03 |
2010-04-20 |
Schering Corporation |
Substituted piperazines as CB1 antagonists
|
|
CA2589699A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Zach System S.P.A. |
Process for the preparation of carvedilol and its enantiomers
|
|
NZ555308A
(en)
*
|
2004-12-22 |
2010-10-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
JP4927566B2
(ja)
*
|
2004-12-28 |
2012-05-09 |
興和株式会社 |
Ｐａｒ−２アゴニスト
|
|
JP2008529995A
(ja)
*
|
2005-02-09 |
2008-08-07 |
クドス ファーマシューティカルズ リミテッド |
Ａｔｍ阻害剤
|
|
US20070142437A1
(en)
*
|
2005-04-08 |
2007-06-21 |
Brown Matthew L |
Chemical compounds
|
|
AR054438A1
(es)
*
|
2005-04-15 |
2007-06-27 |
Kudos Pharm Ltd |
Inhibidores de adn -pk
|
|
US7816405B2
(en)
*
|
2005-04-19 |
2010-10-19 |
Eisai R&D Management Co., Ltd. |
Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
|
|
CN101300248A
(zh)
*
|
2005-04-21 |
2008-11-05 |
塔甘塔治疗公司 |
膦酸酯化的氟喹诺酮、其抗菌类似物以及预防和治疗骨和关节感染的方法
|
|
ES2304911T3
(es)
*
|
2005-05-03 |
2011-05-30 |
Ranbaxy Laboratories Limited |
Sales magnésicas de inhibidores de la reductasa hmg-coa.
|
|
EP1781611A1
(en)
*
|
2005-06-09 |
2007-05-09 |
Teva Pharmaceutical Industries Ltd. |
Crystalline forms of carvedilol and processes for their preparation
|
|
JP5159616B2
(ja)
*
|
2005-06-15 |
2013-03-06 |
カーディオム ファーマ コーポレイション |
アミノシクロヘキシルエーテル化合物の調製のための合成プロセス
|
|
EP1741444A1
(en)
*
|
2005-07-05 |
2007-01-10 |
Jerini AG |
Kinin antagonists for treating bladder dysfunction
|
|
ES2708763T3
(es)
*
|
2005-07-07 |
2019-04-11 |
Seattle Genetics Inc |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
WO2007008848A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
JP2009500378A
(ja)
*
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー／エス |
グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
|
|
JP4960355B2
(ja)
*
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー／エス |
ウレア型グルコキナーゼ活性化剤
|
|
WO2007016496A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
CA2617788A1
(en)
*
|
2005-08-04 |
2007-02-15 |
Apogee Biotechnology Corporation |
Sphingosine kinase inhibitors and methods of their use
|
|
EP1909846B1
(en)
*
|
2005-08-05 |
2018-12-26 |
Syntarga B.V. |
Triazole-containing releasable linkers, conjugates comprising the same and processes for their preparation
|
|
US8293708B2
(en)
*
|
2005-08-30 |
2012-10-23 |
Novo Nordisk Health Care A/G |
Liquid formulations N-terminal serine of pegylated growth hormone
|
|
ES2393117T3
(es)
|
2005-09-12 |
2012-12-18 |
Actelion Pharmaceuticals Ltd. |
Composición farmacéutica estable que comprende una pirimidina-sulfamida
|
|
EP1937632A1
(en)
|
2005-10-06 |
2008-07-02 |
Astra Zeneca AB |
Novel compounds
|
|
TW200745003A
(en)
|
2005-10-06 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
US20070086957A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Thierry Bouyssou |
Combination of medicaments for the treatment of respiratory diseases
|
|
US20080255150A1
(en)
*
|
2005-11-05 |
2008-10-16 |
Astrazeneca Ab |
Novel Compounds
|
|
HRP20110404T1
(hr)
*
|
2005-11-08 |
2011-08-31 |
Ambrx |
Ubrzivači za modifikaciju ne-prirodnih aminokiselina i polipeptida ne-prirodnih aminokiselina
|
|
PT103385B
(pt)
*
|
2005-11-15 |
2011-06-27 |
Jorge Ruas Da Silva |
Ácido 2,3,4,5-tetrahidróxi-6-sulfooxi-hexanoico, seus sais farmaceuticamente aceitáveis e suas formas de equilíbrio, processo para a sua preparação, composições farmacêuticas contendo estes compostos e seu uso em medicina
|
|
US7714014B2
(en)
*
|
2005-12-09 |
2010-05-11 |
The Regents Of The University Of California |
Targeting GLI proteins in human cancer by small molecules
|
|
WO2007070563A2
(en)
*
|
2005-12-13 |
2007-06-21 |
Harkness Pharmaceuticals, Inc. |
Stable solid forms of enterostatin
|
|
WO2007070562A2
(en)
*
|
2005-12-13 |
2007-06-21 |
Harkness Pharmaceuticals, Inc. |
Non-hygroscopic compositions of enterostatin
|
|
WO2007070564A2
(en)
*
|
2005-12-13 |
2007-06-21 |
Harkness Pharmaceuticals, Inc. |
Methods of treating obesity using enterostatin
|
|
KR101423898B1
(ko)
*
|
2005-12-14 |
2014-07-28 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
|
|
ES2380683T3
(es)
*
|
2005-12-15 |
2012-05-17 |
Astrazeneca Ab |
Difenil-éteres, -amidas, -sulfuros y - metanos sustituidos para el tratamiento de la enfermedad respiratoria
|
|
WO2007077111A1
(en)
*
|
2005-12-30 |
2007-07-12 |
F. Hoffmann-La Roche Ag |
Compounds and methods for carbazole synthesis
|
|
US8975404B2
(en)
*
|
2006-01-24 |
2015-03-10 |
Dh Technologies Development Pte. Ltd. |
Labeling reagents for analyte determination and methods and compounds used in making the same
|
|
DE102006003443A1
(de)
*
|
2006-01-25 |
2007-07-26 |
Aicuris Gmbh & Co. Kg |
Asparagin-10-substituierte Nonadepsipeptide
|
|
KR100746455B1
(ko)
*
|
2006-02-23 |
2007-08-03 |
안국약품 주식회사 |
고광학순도의 키랄 카베딜롤의 제조방법
|
|
CA2643826A1
(en)
*
|
2006-02-27 |
2008-06-12 |
Paul A. Wender |
Compositions and methods for transport of molecules with enhanced release properties across biological barriers
|
|
US8367112B2
(en)
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
MX2008012225A
(es)
*
|
2006-03-23 |
2008-12-03 |
Schering Corp |
Combinaciones de inhibidores de proteasa de virus de hepatitis c e inhibidores de isoenzima 3a4 del citocromo p450, y metodos de tratamiento relacionados con las mismas.
|
|
WO2007110449A1
(en)
*
|
2006-03-29 |
2007-10-04 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use
|
|
CN101460495B
(zh)
|
2006-03-31 |
2013-08-14 |
财团法人乙卯研究所 |
具有杂环的化合物
|
|
WO2007118853A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
|
DE102006018080A1
(de)
*
|
2006-04-13 |
2007-10-18 |
Aicuris Gmbh & Co. Kg |
Lysobactinamide
|
|
TW200812963A
(en)
*
|
2006-04-13 |
2008-03-16 |
Euro Celtique Sa |
Benzenesulfonamide compounds and the use thereof
|
|
DE102006018250A1
(de)
*
|
2006-04-13 |
2007-10-18 |
Aicuris Gmbh & Co. Kg |
Verfahren zum Herstellen von cyclischen Depsipeptiden
|
|
UA93548C2
(uk)
*
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
WO2007146085A2
(en)
*
|
2006-06-06 |
2007-12-21 |
Xenoport, Inc. |
Creatine phosphate prodrugs, compositions and uses thereof
|
|
WO2007146088A1
(en)
*
|
2006-06-06 |
2007-12-21 |
Xenoport, Inc. |
Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof
|
|
WO2007146086A1
(en)
*
|
2006-06-06 |
2007-12-21 |
Xenoport, Inc. |
Creatine prodrugs, compositions and uses thereof
|
|
US20070281983A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Xenoport, Inc. |
Creatine analog prodrugs, compositions and uses thereof
|
|
US7683043B2
(en)
*
|
2006-06-06 |
2010-03-23 |
Xenoport, Inc. |
Creatine phosphate analog prodrugs, compositions and uses thereof
|
|
WO2008002683A2
(en)
*
|
2006-06-28 |
2008-01-03 |
Teva Pharmaceutical Industries Ltd. |
Polymorphous forms of carvedilol phosphate
|
|
US8088733B2
(en)
*
|
2006-07-06 |
2012-01-03 |
Tranzyme Pharma Inc. |
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
|
|
WO2008003750A2
(en)
*
|
2006-07-07 |
2008-01-10 |
Novo Nordisk Health Care Ag |
New protein conjugates and methods for their preparation
|
|
CA2659412A1
(en)
*
|
2006-07-31 |
2008-02-07 |
Janssen Pharmaceutica N.V. |
Urotensin ii receptor antagonists
|
|
US7867988B2
(en)
|
2006-09-13 |
2011-01-11 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
|
US8088789B2
(en)
|
2006-09-13 |
2012-01-03 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
|
US10695327B2
(en)
|
2006-09-13 |
2020-06-30 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
|
GB2442238B
(en)
*
|
2006-09-29 |
2008-10-01 |
Rolls Royce Plc |
Sheet metal blank
|
|
EP2091953A1
(en)
*
|
2006-10-30 |
2009-08-26 |
BIOVITRUM AB (publ) |
8-sulfonyl-l, 3, 4, 8-tetrahydr0-2h- [1, 4]oxazepino [6, 7-e]indole derivatives and their use as 5-ht6 receptor ligands
|
|
WO2008070072A2
(en)
*
|
2006-12-01 |
2008-06-12 |
Mutual Pharmaceutical Company, Inc. |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
JP2010515701A
(ja)
*
|
2007-01-09 |
2010-05-13 |
ノボ・ノルデイスク・エー／エス |
ウレアグルコキナーゼアクチベーター
|
|
AU2008204530B2
(en)
*
|
2007-01-11 |
2013-08-01 |
Vtv Therapeutics Llc |
Urea glucokinase activators
|
|
CZ302357B6
(cs)
*
|
2007-01-26 |
2011-03-30 |
Zentiva, A. S. |
Zpusob cištení Carvedilolu
|
|
US20080249317A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Apotex Inc. |
Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
|
|
WO2008124118A1
(en)
*
|
2007-04-09 |
2008-10-16 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use therof
|
|
DE102007026550A1
(de)
*
|
2007-06-08 |
2008-12-11 |
Bayer Healthcare Ag |
Extrudate mit verbesserter Geschmacksmaskierung
|
|
UA100983C2
(ru)
*
|
2007-07-05 |
2013-02-25 |
Астразенека Аб |
Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
|
|
GB0714030D0
(en)
*
|
2007-07-18 |
2007-08-29 |
Novacta Biosystems Ltd |
The use of type-B lantibiotic-based compounds having antimicrobial activity
|
|
UY31232A1
(es)
*
|
2007-07-19 |
2009-03-02 |
|
Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
|
|
MX2010001837A
(es)
|
2007-08-17 |
2010-03-10 |
Actelion Pharmaceuticals Ltd |
Derivados de 4-pirimidinasulfamida.
|
|
WO2009024997A1
(en)
|
2007-08-21 |
2009-02-26 |
Lupin Limited |
Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer
|
|
US20090076116A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched carvediolo
|
|
WO2009040659A2
(en)
*
|
2007-09-28 |
2009-04-02 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
|
FR2927809B1
(fr)
*
|
2008-02-26 |
2011-01-14 |
Tri Inov |
Nouvelle utilisation de n-acetyl-taurinate de zinc.
|
|
WO2009111688A2
(en)
*
|
2008-03-06 |
2009-09-11 |
Wisconsin Alumni Research Foundation |
All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof
|
|
AU2009225869B2
(en)
*
|
2008-03-18 |
2014-01-23 |
Merck Sharp & Dohme Llc |
Substituted 4-hydroxypyrimidine-5-carboxamides
|
|
WO2009115902A1
(en)
*
|
2008-03-19 |
2009-09-24 |
Cadila Pharmaceuticals Ltd. |
Process for the preparation of carvedilol via silyl protection of substituted amine
|
|
US9023809B2
(en)
*
|
2008-03-27 |
2015-05-05 |
The Key Laboratory Of Chemistry For Natural Products Of Guizhou Province And Chinese Academy Of Sciences |
Phenylalanine dipeptide derivatives, compositions and use thereof
|
|
RS60101B1
(sr)
|
2008-08-15 |
2020-05-29 |
Ironwood Pharmaceuticals Inc |
Formulacije koje sadrže linaklotid za oralnu primenu
|
|
EP2157432A1
(en)
*
|
2008-08-15 |
2010-02-24 |
Qiagen GmbH |
Method for analysing a complex sample by mass spectrometry
|
|
WO2010042834A1
(en)
*
|
2008-10-09 |
2010-04-15 |
Anadys Pharmaceuticals, Inc. |
A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
|
|
US20100197567A1
(en)
*
|
2008-10-17 |
2010-08-05 |
University Of Utah Research Foundation |
Conus polypeptides
|
|
AU2009317549A1
(en)
*
|
2008-11-20 |
2011-07-07 |
Merck Patent Gmbh |
New therapy and medicament using integrin ligands for treating cancer
|
|
EP2370104A1
(en)
*
|
2008-11-25 |
2011-10-05 |
Novo Nordisk A/S |
Peptides for treatment of obesity
|
|
AU2010214101A1
(en)
|
2009-02-11 |
2011-09-01 |
Sunovion Pharmaceuticals Inc. |
Histamine H3 inverse agonists and antagonists and methods of use thereof
|
|
US8748573B2
(en)
*
|
2009-08-06 |
2014-06-10 |
Ironwood Pharmaceuticals, Inc. |
Formulations comprising linaclotide
|
|
US20130203861A1
(en)
*
|
2009-09-09 |
2013-08-08 |
Golden Biotechnology Corporation |
Methods and compositions for treating ovarian cancer
|
|
JP2013504580A
(ja)
*
|
2009-09-11 |
2013-02-07 |
スノヴィオン ファーマシューティカルズ インコーポレイテッド |
ヒスタミンｈ３インバースアゴニストおよびアンタゴニストとその使用方法
|
|
EP2528894A1
(en)
|
2010-01-27 |
2012-12-05 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
|
GB201001688D0
(en)
|
2010-02-02 |
2010-03-17 |
Novacta Biosystems Ltd |
Compounds
|
|
CA2790213A1
(en)
|
2010-02-17 |
2011-08-25 |
Ironwood Pharmaceuticals, Inc. |
Treatments for gastrointestinal disorders
|
|
CN102190613B
(zh)
*
|
2010-03-14 |
2014-06-25 |
浙江华海药业股份有限公司 |
一种卡维地洛的制备方法
|
|
ES2763404T3
(es)
|
2010-08-11 |
2020-05-28 |
Ironwood Pharmaceuticals Inc |
Formulaciones estables de linaclotida
|
|
GB201013513D0
(en)
|
2010-08-11 |
2010-09-22 |
Novacta Biosystems Ltd |
Formulations
|
|
WO2012026988A2
(en)
*
|
2010-08-27 |
2012-03-01 |
New York University |
Dendrimeric peptides, pharmaceutical compositions and methods of using the same
|
|
CN103221410B
(zh)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
Gpr119受体调节剂和对与其相关的障碍的治疗
|
|
WO2012107244A1
(en)
*
|
2011-02-09 |
2012-08-16 |
Organobalance Gmbh |
Peptide for use in the treatment of skin conditions
|
|
TW201300105A
(zh)
|
2011-05-31 |
2013-01-01 |
Piramal Life Sciences Ltd |
治療頭頸鱗狀細胞癌之相乘藥物組合物
|
|
CN104053449B
(zh)
|
2011-08-17 |
2016-12-07 |
硬木药品公司 |
胃肠疾患的治疗
|
|
EP2825534A1
(en)
*
|
2012-03-16 |
2015-01-21 |
Sandoz AG |
Process for the synthesis of telaprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof
|
|
US9816066B2
(en)
|
2012-04-24 |
2017-11-14 |
The Regents Of The University Of California |
Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
|
|
US8492426B1
(en)
*
|
2012-07-12 |
2013-07-23 |
Anis Ahmad |
Use of carvedilol for treatment of diabetes mellitus
|
|
US20150299250A1
(en)
*
|
2012-11-16 |
2015-10-22 |
Adelaide Research & Innovation Pty Ltd |
Macrocyclic compounds and uses thereof
|
|
US20150361139A1
(en)
*
|
2013-01-30 |
2015-12-17 |
Sandoz Ag |
Crystalline form of linaclotide
|
|
WO2014191575A1
(en)
*
|
2013-05-31 |
2014-12-04 |
Centre National De La Recherche Scientique (Cnrs) |
Protein involved in dna replication, and modulation of its activity
|
|
TWI839690B
(zh)
|
2013-07-12 |
2024-04-21 |
印度商皮拉馬爾企業有限公司 |
治療黑色素瘤的藥物組合的用途
|
|
CA2917767C
(en)
*
|
2013-07-12 |
2022-05-03 |
Helmholtz-Zentrum Fur Infektionsforschung Gmbh |
Cystobactamides
|
|
US12091408B2
(en)
*
|
2013-08-30 |
2024-09-17 |
Uti Limited Partnership |
Store overload-induced calcium release inhibitors and methods for producing and using the same
|
|
EP3071591B1
(en)
|
2014-01-22 |
2021-05-05 |
Agency For Science, Technology And Research |
Antimicrobial peptidomimetics
|
|
WO2015113760A1
(en)
|
2014-01-28 |
2015-08-06 |
Tube Pharmaceuticals Gmbh |
Cytotoxic tubulysin compounds for conjugation
|
|
CA2968270C
(en)
|
2014-11-26 |
2022-11-01 |
Helmholtz-Zentrum Fur Infektionsforschung Gmbh |
Further natural cystobactamides, synthetic derivatives thereof, and use thereof in treating bacterial infections
|
|
CN104592096A
(zh)
*
|
2014-12-24 |
2015-05-06 |
江苏苏南药业实业有限公司 |
一种s-卡维地洛的制备方法
|
|
CA3002540C
(en)
|
2015-01-06 |
2023-11-07 |
Arena Pharmaceuticals, Inc. |
Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
|
|
JP6838744B2
(ja)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
|
|
CN110520124A
(zh)
|
2017-02-16 |
2019-11-29 |
艾尼纳制药公司 |
用于治疗原发性胆汁性胆管炎的化合物和方法
|
|
JP7235748B2
(ja)
|
2017-11-30 |
2023-03-08 |
ハンミ ファーム．カンパニー リミテッド |
４－アミノ－ｎ－（１－（（３－クロロ－２－フルオロフェニル）アミノ）－６－メチルイソキノリン－５－イル）チエノ［３，２－ｄ］ピリミジン－７－カルボキサミドの塩とその結晶形態
|
|
JP7397011B2
(ja)
|
2018-06-06 |
2023-12-12 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１ｐ１受容体に関連する状態を治療する方法
|
|
CA3093025A1
(en)
|
2018-06-12 |
2019-12-19 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
|
US10357476B1
(en)
|
2018-10-30 |
2019-07-23 |
Anis Ahmad |
Method for treating coronary artery disease
|
|
US10772869B1
(en)
|
2019-07-24 |
2020-09-15 |
ECI Pharmaceuticals, LLC |
Pharmaceutical compositions including carvedilol and methods of using the same
|
|
CN110790817A
(zh)
*
|
2019-11-12 |
2020-02-14 |
成都诺和晟泰生物科技有限公司 |
一种多肽类化合物、制剂、药物组合物及制备方法、应用
|
|
US12391658B2
(en)
|
2020-02-18 |
2025-08-19 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
GB202215797D0
(en)
*
|
2022-10-25 |
2022-12-07 |
Solasta Bio Ltd |
Insect neuropeptide analogues
|
|
AU2023410324A1
(en)
*
|
2022-12-22 |
2025-05-15 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of a her2 inhibitor
|
|
US12302908B2
(en)
|
2023-10-23 |
2025-05-20 |
Solasta Bio Limited |
Insect neuropeptides 4
|
|
US12281143B1
(en)
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 1
|
|
US12279621B1
(en)
*
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 3
|
|
US12245588B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 2
|
|
US12245596B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 8
|
|
US12356995B2
(en)
|
2023-10-23 |
2025-07-15 |
Solasta Bio Limited |
Insect neuropeptides 9
|